1. Shilpa Medicare
stock logo

100% Buy

Shilpa Medicare Share Price

SHILPAMED

₹866.65+₹18.60 (2.19%) TodayLast updated on 20 Sep, 2024 | 15:52 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹8,293 Crs

Open

₹853.40

Close

₹848.05

Circuit range

₹1,039.95 - ₹693.35

Day range

₹846.55 - ₹869.40

Year range

₹296.80 - ₹959.50

Volume

2,24,041

Avg. traded

₹857.98

Revenue (12m)

₹1,184 Crs

Shilpa MedicareShilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.

Shilpa Medicare Key indicators

arrow

52 week high

₹959.50

52 week low

₹296.80

P/E ratio

173.5

P/B ratio

3.8

ROE

1.26%

ROCE

2.36%

Dividend yield

--

Debt/Equity ratio

0.07

EPS

3.1

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

37.25%

Net profit margin

8.7%

ROE

1.26%

ROA

1.09%

ROCE

2.36%

Learn more

Shilpa Medicare Shareholder returns

arrow

1 day

+2.19%

1 week

-1.83%

1 month

+26.36%

3 months

+51.43%

1 year

+145.02%

3 years

+56.36%

5 years

+244.46%

Shilpa Medicare Share Price history

arrow
DayOpenCloseDay’s change
Fri, Sep 20 2024
₹853.40
₹866.65
+2.19%
Thu, Sep 19 2024
₹912.70
₹848.05
-5.97%
Wed, Sep 18 2024
₹883.00
₹901.90
+2.42%
Tue, Sep 17 2024
₹895.15
₹880.60
-1.58%
Mon, Sep 16 2024
₹905.20
₹894.70
+1.34%
Fri, Sep 13 2024
₹890.90
₹882.85
-1.08%
Thu, Sep 12 2024
₹878.65
₹892.50
+1.95%
Wed, Sep 11 2024
₹845.00
₹875.45
+3.99%

Shareholding info

arrow

Promoters (44.39%)

Mutual Funds (5.03%)

Retail and other (38.92%)

Foreign institutions-FII (9.08%)

Other domestic institutions (2.58%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹1.1/share

    Ex date 19 Sep 2022

    expand tab

Learn more

Frequently asked questions